Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-9378
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Interim results of a clinical trial using oncolytic virotherapy in Kaposi's sarcoma-associated herpesvirus (KSHV) associated-Multicentric Castleman's Disease (MCD) ; volume:4 ; number:2 ; day:17 ; month:6 ; year:2009 ; pages:1-2 ; date:6.2009
Infectious agents and cancer ; 4, Heft 2 (17.6.2009), 1-2, 6.2009
- Creator
-
Yarchoan, R.
- Contributor
-
O'Mahony, D.
Aleman, K.
Wyvill, KM
Whitby, D.
Bernstein, W.
Pittaluga, S.
Jaffe, ES
Tosato, G.
Davis, DA
Steinberg, SM
Little, RF
SpringerLink (Online service)
- DOI
-
10.1186/1750-9378-4-S2-O20
- URN
-
urn:nbn:de:1111-2016072622935
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:02 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yarchoan, R.
- O'Mahony, D.
- Aleman, K.
- Wyvill, KM
- Whitby, D.
- Bernstein, W.
- Pittaluga, S.
- Jaffe, ES
- Tosato, G.
- Davis, DA
- Steinberg, SM
- Little, RF
- SpringerLink (Online service)
Other Objects (12)
Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
In vitro analysis of the impact of Kaposi’s sarcoma-associated herpesvirus (KSHV) on experimentally induced necroptosis
Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
A genome wide analysis of protein-protein interactions in Kaposi's sarcoma associated herpesvirus (KSHV)
KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman's disease
Rituximab and Castleman disease and Kaposi's sarcoma
Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
In vitro analysis of the impact of Kaposi’s sarcoma-associated herpesvirus (KSHV) on experimentally induced necroptosis
Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
A genome wide analysis of protein-protein interactions in Kaposi's sarcoma associated herpesvirus (KSHV)
KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman's disease
Rituximab and Castleman disease and Kaposi's sarcoma
Parasite infection is associated with Kaposi's sarcoma associated herpesvirus (KSHV) in Ugandan women
Rituximab combined with liposomal doxorubicin (R-Dox) in HIV-infected patients with severe Kaposi sarcoma-associated herpes virus (KSHV) associated multicentric Castleman disease (MCD)
Kaposi’s sarcoma-associated herpesvirus (KSHV) serum DNA not associated with subsequent non-Hodgkin’s lymphoma (NHL) risk
Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
Transient induction of lytic Kaposi's sarcoma-associated herpesvirus (KSHV) genes in KSHV-infected endothelial cells exposed to hypoxia
Kaposi's Sarcoma Associated-Herpes Virus (KSHV) Seroprevalence in Pregnant Women in South Africa
Distinct profiles of antibodies to Kaposi sarcoma-associated herpesvirus antigens in patients with Kaposi sarcoma, multicentric Castleman’s disease, and primary effusion lymphoma
In vitro analysis of the impact of Kaposi’s sarcoma-associated herpesvirus (KSHV) on experimentally induced necroptosis
Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
A genome wide analysis of protein-protein interactions in Kaposi's sarcoma associated herpesvirus (KSHV)
KSHV activation, human and viral IL-6 production, and other cytokine dysregulation: Association with the symptomatology of KSHV-associated multicentric Castleman's disease